Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The bupropion-related subcortical changes in a depression patient.

Lai CH.

Aust N Z J Psychiatry. 2015 Dec;49(12):1224. doi: 10.1177/0004867415580819. Epub 2015 Apr 1. No abstract available.

PMID:
25834136
2.

Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.

Greven CU, Bralten J, Mennes M, O'Dwyer L, van Hulzen KJ, Rommelse N, Schweren LJ, Hoekstra PJ, Hartman CA, Heslenfeld D, Oosterlaan J, Faraone SV, Franke B, Zwiers MP, Arias-Vasquez A, Buitelaar JK.

JAMA Psychiatry. 2015 May;72(5):490-9. doi: 10.1001/jamapsychiatry.2014.3162.

PMID:
25785435
3.

Decreased subcortical volumes in alcohol dependent individuals: effect of polysubstance use disorder.

Grodin EN, Momenan R.

Addict Biol. 2017 Sep;22(5):1426-1437. doi: 10.1111/adb.12421. Epub 2016 Jun 23.

4.

Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson's Disease and Their First-Degree Unaffected Relatives.

Thaler A, Kliper E, Maidan I, Herman T, Rosenberg-Katz K, Bregman N, Gurevich T, Shiner T, Hausdorff JM, Orr-Urtreger A, Giladi N, Mirelman A.

Brain Topogr. 2018 Nov;31(6):1029-1036. doi: 10.1007/s10548-018-0653-8. Epub 2018 May 30.

PMID:
29846835
5.

Extensive deep gray matter volume reductions in children and adolescents with fetal alcohol spectrum disorders.

Nardelli A, Lebel C, Rasmussen C, Andrew G, Beaulieu C.

Alcohol Clin Exp Res. 2011 Aug;35(8):1404-17. doi: 10.1111/j.1530-0277.2011.01476.x. Epub 2011 May 16.

PMID:
21575012
6.

Amygdala volume is reduced in early course schizophrenia.

Rich AM, Cho YT, Tang Y, Savic A, Krystal JH, Wang F, Xu K, Anticevic A.

Psychiatry Res Neuroimaging. 2016 Apr 30;250:50-60. doi: 10.1016/j.pscychresns.2016.02.006. Epub 2016 Feb 12.

7.

Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage.

Bogerts B, Meertz E, Schönfeldt-Bausch R.

Arch Gen Psychiatry. 1985 Aug;42(8):784-91.

PMID:
4015323
8.

Heritability of subcortical volumetric traits in mesial temporal lobe epilepsy.

Alhusaini S, Scanlon C, Ronan L, Maguire S, Meaney JF, Fagan AJ, Boyle G, Borgulya G, Iyer PM, Brennan P, Costello D, Chaila E, Fitzsimons M, Doherty CP, Delanty N, Cavalleri GL.

PLoS One. 2013 Apr 23;8(4):e61880. doi: 10.1371/journal.pone.0061880. Print 2013.

9.

[A 3.0 T MRI study on the alterations of the volume and morphology of fifteen subcortical nucleus in patients with early post-stroke depression].

Chen Y, Wu MX, Gong JS, Zou LY, Xu JM, Zhu J, Li G.

Zhonghua Yi Xue Za Zhi. 2018 Aug 21;98(31):2471-2475. doi: 10.3760/cma.j.issn.0376-2491.2018.31.004. Chinese.

PMID:
30138997
10.

Bupropion in the treatment of depression in Parkinson's disease.

Załuska M, Dyduch A.

Int Psychogeriatr. 2011 Mar;23(2):325-7. doi: 10.1017/S1041610210001687.

PMID:
20809995
11.

Bupropion: efficacy and safety in the treatment of depression.

Saiz Ruiz J, Gibert J, Gutiérrez Fraile M, Bobes J, Vallejo J, Iglesias C, Iriarte V.

Actas Esp Psiquiatr. 2011;39 Suppl 1:1-25. Epub 2011 Jan 1. Review. English, Spanish. No abstract available.

PMID:
22983817
12.

Volume changes of corpus striatum, thalamus, hippocampus and lateral ventricles in posttraumatic stress disorder (PTSD) patients suffering from headaches and without therapy.

Filipovic BR, Djurovic B, Marinkovic S, Stijak L, Aksic M, Nikolic V, Starcevic A, Radonjic V.

Cent Eur Neurosurg. 2011 Aug;72(3):133-7. doi: 10.1055/s-0030-1253349. Epub 2010 Sep 20.

PMID:
20857373
13.

Paroxetine/bupropion combination treatment for refractory depression.

Marshall RD, Liebowitz MR.

J Clin Psychopharmacol. 1996 Feb;16(1):80-1. No abstract available.

PMID:
8834426
14.

Bupropion-tranylcypromine combination for treatment-refractory depression.

Pierre JM, Gitlin MJ.

J Clin Psychiatry. 2000 Jun;61(6):450-1. No abstract available.

PMID:
10901349
15.

Brain alterations in adult ADHD: effects of gender, treatment and comorbid depression.

Onnink AM, Zwiers MP, Hoogman M, Mostert JC, Kan CC, Buitelaar J, Franke B.

Eur Neuropsychopharmacol. 2014 Mar;24(3):397-409. doi: 10.1016/j.euroneuro.2013.11.011. Epub 2013 Dec 1.

16.

Subcortical structural volumes in recently remitted first episode mania.

Arumugham SS, Torres IJ, Lang DJ, Su W, Lam RW, Honer WG, Yatham LN.

J Affect Disord. 2017 Nov;222:23-27. doi: 10.1016/j.jad.2017.06.051. Epub 2017 Jun 24.

PMID:
28667890
17.

Bupropion-induced hypomania in a patient with unipolar depression.

Hussain H, Butt MA.

Aust N Z J Psychiatry. 2008 Aug;42(8):746. doi: 10.1080/00048670802206353. No abstract available.

PMID:
18622783
18.

Subcortical nuclei volumetry in idiopathic generalized epilepsy.

Seeck M, Dreifuss S, Lantz G, Jallon P, Foletti G, Despland PA, Delavelle J, Lazeyras F.

Epilepsia. 2005 Oct;46(10):1642-5.

19.

Subcortical volumetric reductions in adult Niemann-Pick disease type C: a cross-sectional study.

Walterfang M, Patenaude B, Abel LA, Kluenemann H, Bowman EA, Fahey MC, Desmond P, Kelso W, Velakoulis D.

AJNR Am J Neuroradiol. 2013 Jul;34(7):1334-40. doi: 10.3174/ajnr.A3356. Epub 2012 Dec 13.

20.

Foreword. A comprehensive review of bupropion.

Lader M.

Clin Drug Investig. 2011 Oct 19;31 Suppl 1:1-3. No abstract available.

PMID:
22125799

Supplemental Content

Support Center